financetom
Business
financetom
/
Business
/
Home Depot Unusual Options Activity For March 21
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Home Depot Unusual Options Activity For March 21
Mar 21, 2024 9:03 AM

Deep-pocketed investors have adopted a bullish approach towards Home Depot ( HD ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HD usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 32 extraordinary options activities for Home Depot ( HD ). This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 56% leaning bullish and 43% bearish. Among these notable options, 4 are puts, totaling $166,580, and 28 are calls, amounting to $1,331,341.

Expected Price Movements

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $330.0 and $450.0 for Home Depot ( HD ), spanning the last three months.

Volume & Open Interest Trends

In today's trading context, the average open interest for options of Home Depot ( HD ) stands at 451.62, with a total volume reaching 6,884.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Home Depot ( HD ), situated within the strike price corridor from $330.0 to $450.0, throughout the last 30 days.

Home Depot 30-Day Option Volume & Interest Snapshot

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
HD CALL TRADE BULLISH 01/16/26 $400.00 $107.7K 134 22
HD CALL TRADE BEARISH 01/16/26 $420.00 $79.7K 135 2
HD PUT SWEEP BEARISH 05/17/24 $380.00 $58.5K 165 352
HD CALL SWEEP BULLISH 06/21/24 $380.00 $57.7K 1.8K 254
HD CALL SWEEP BULLISH 06/21/24 $380.00 $57.5K 1.8K 212

About Home Depot

Home Depot ( HD ) is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot ( HD ) to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). Moreover, the additions of the Company Store brought textile exposure to the lineup, while Redi Carpet added multifamily flooring.

Following our analysis of the options activities associated with Home Depot ( HD ), we pivot to a closer look at the company's own performance.

Home Depot's Current Market Status

With a volume of 1,312,727, the price of HD is up 2.96% at $395.77.

RSI indicators hint that the underlying stock may be overbought.

Next earnings are expected to be released in 54 days.

Expert Opinions on Home Depot

Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $396.6.

Consistent in their evaluation, an analyst from RBC Capital keeps a Sector Perform rating on Home Depot ( HD ) with a target price of $377.

An analyst from Citigroup has decided to maintain their Buy rating on Home Depot ( HD ), which currently sits at a price target of $415.

An analyst from Mizuho downgraded its action to Buy with a price target of $415.

Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Home Depot ( HD ) with a target price of $386.

Maintaining their stance, an analyst from Guggenheim continues to hold a Buy rating for Home Depot ( HD ), targeting a price of $390.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Home Depot ( HD ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Berkshire's PacifiCorp ordered to pay $29.2 million to homeowners, summer camp for 2020 Oregon wildfire damage
Berkshire's PacifiCorp ordered to pay $29.2 million to homeowners, summer camp for 2020 Oregon wildfire damage
Mar 5, 2024
(Reuters) - An Oregon state jury on Tuesday ordered Berkshire Hathaway's ( BRK/A ) PacifiCorp ( PPWLM ) to pay at least $29.2 million to nine homeowners and a summer camp whose properties were damaged by 2020 wildfires they claim were sparked when the Oregon utility failed to shut off its power lines during high winds. The verdict came in...
Nektar Therapeutics Begins Phase 2b Trial for Rezpegaldesleukin in Patients With Severe Alopecia Areata
Nektar Therapeutics Begins Phase 2b Trial for Rezpegaldesleukin in Patients With Severe Alopecia Areata
Mar 5, 2024
04:04 PM EST, 03/05/2024 (MT Newswires) -- Nektar Therapeutics ( NKTR ) said Tuesday it started the phase 2b trial for rezpegaldesleukin to treat patients experiencing severe to very severe alopecia areata. The Phase 2b study will evaluate rezpegaldesleukin's efficacy and safety in 84 participants with severe alopecia areata over a 36-week period using a randomized, double-blind, placebo-controlled dosage, Nektar...
Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why
Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why
Mar 5, 2024
Immutep Limited ( IMMP ) announces safety and initial efficacy data from the first ever 90mg dosing of eftilagimod alpha (efti) in combination with weekly paclitaxel in patients from the safety lead-in (N=6) of the AIPAC-003 Phase 2/3 trial. Updated safety data from patients with HR-positive/HER2-negative/low metastatic breast cancer (MBC) treated with this immuno-oncology (IO)-chemotherapy combination reveal no treatment-emergent serious adverse events. ...
Campbell Soup Positioned For Largely In-Line Second Quarter, RBC Says
Campbell Soup Positioned For Largely In-Line Second Quarter, RBC Says
Mar 5, 2024
04:02 PM EST, 03/05/2024 (MT Newswires) -- Campbell Soup ( CPB ) is positioned for a largely in-line fiscal second quarter with possible top-line upside amid strong January soup trends, though the consumer packaged food industry remains challenged, RBC Capital Markets said Tuesday. Campbell's salty snacks category continues to slow and its soup business faces pressure from a trade-down to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved